Cargando…
MicroRNAs in melanoma development and resistance to target therapy
microRNAs constitute a complex class of pleiotropic post-transcriptional regulators of gene expression involved in the control of several physiologic and pathologic processes. Their mechanism of action is primarily based on the imperfect matching of a seed region located at the 5′ end of a 21-23 nt...
Autores principales: | Fattore, Luigi, Costantini, Susan, Malpicci, Debora, Ruggiero, Ciro Francesco, Ascierto, Paolo Antonio, Croce, Carlo M., Mancini, Rita, Ciliberto, Gennaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400662/ https://www.ncbi.nlm.nih.gov/pubmed/28118616 http://dx.doi.org/10.18632/oncotarget.14763 |
Ejemplares similares
-
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization
por: Fattore, Luigi, et al.
Publicado: (2020) -
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin
por: Ruggiero, Ciro Francesco, et al.
Publicado: (2019) -
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
por: Fattore, Luigi, et al.
Publicado: (2019) -
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021) -
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
por: Fattore, Luigi, et al.
Publicado: (2018)